Annual EBITDA
-$92.20 M
-$4.14 M-4.70%
December 31, 2023
Summary
- As of February 24, 2025, VERA annual EBITDA is -$92.20 million, with the most recent change of -$4.14 million (-4.70%) on December 31, 2023.
- During the last 3 years, VERA annual EBITDA has fallen by -$39.21 million (-73.98%).
- VERA annual EBITDA is now -716.46% below its all-time high of -$11.29 million, reached on December 31, 2019.
Performance
VERA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$44.67 M
-$14.37 M-47.43%
September 30, 2024
Summary
- As of February 24, 2025, VERA quarterly EBITDA is -$44.67 million, with the most recent change of -$14.37 million (-47.43%) on September 30, 2024.
- Over the past year, VERA quarterly EBITDA has stayed the same.
- VERA quarterly EBITDA is now -1807.43% below its all-time high of -$2.34 million, reached on March 31, 2020.
Performance
VERA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$126.05 M
-$25.52 M-25.38%
September 30, 2024
Summary
- As of February 24, 2025, VERA TTM EBITDA is -$126.05 million, with the most recent change of -$25.52 million (-25.38%) on September 30, 2024.
- Over the past year, VERA TTM EBITDA has stayed the same.
- VERA TTM EBITDA is now -5282.07% below its all-time high of -$2.34 million, reached on March 31, 2020.
Performance
VERA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VERA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.7% | 0.0% | 0.0% |
| 3 y3 years | -74.0% | 0.0% | 0.0% |
| 5 y5 years | -716.5% | 0.0% | 0.0% |
VERA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -184.5% | at low | -203.4% | at low | -288.9% | at low |
| 5 y | 5-year | -716.5% | at low | -1807.4% | at low | -5282.1% | at low |
| alltime | all time | -716.5% | at low | -1807.4% | at low | -5282.1% | at low |
Vera Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$44.67 M(+47.4%) | -$126.05 M(+25.4%) |
| Jun 2024 | - | -$30.30 M(+14.4%) | -$100.53 M(+13.0%) |
| Mar 2024 | - | -$26.48 M(+7.6%) | -$88.96 M(-3.0%) |
| Dec 2023 | -$92.20 M(+4.7%) | -$24.60 M(+28.4%) | -$91.68 M(-7.3%) |
| Sep 2023 | - | -$19.16 M(+2.3%) | -$98.92 M(-5.2%) |
| Jun 2023 | - | -$18.73 M(-35.8%) | -$104.30 M(+4.0%) |
| Mar 2023 | - | -$29.20 M(-8.3%) | -$100.29 M(+13.9%) |
| Dec 2022 | -$88.06 M | -$31.84 M(+29.8%) | -$88.05 M(+20.6%) |
| Sep 2022 | - | -$24.53 M(+66.6%) | -$73.01 M(+30.3%) |
| Jun 2022 | - | -$14.72 M(-13.2%) | -$56.03 M(+25.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$16.96 M(+1.0%) | -$44.69 M(+37.9%) |
| Dec 2021 | -$32.41 M(-38.8%) | -$16.79 M(+122.4%) | -$32.41 M(-44.6%) |
| Sep 2021 | - | -$7.55 M(+123.0%) | -$58.48 M(+7.0%) |
| Jun 2021 | - | -$3.39 M(-27.6%) | -$54.65 M(-0.1%) |
| Mar 2021 | - | -$4.68 M(-89.1%) | -$54.69 M(+4.5%) |
| Dec 2020 | -$52.99 M(+369.3%) | - | - |
| Dec 2020 | - | -$42.86 M(+1051.2%) | -$52.35 M(+451.4%) |
| Sep 2020 | - | -$3.72 M(+8.6%) | -$9.49 M(+64.5%) |
| Jun 2020 | - | -$3.43 M(+46.4%) | -$5.77 M(+146.4%) |
| Mar 2020 | - | -$2.34 M | -$2.34 M |
| Dec 2019 | -$11.29 M | - | - |
FAQ
- What is Vera Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Vera Therapeutics?
- What is Vera Therapeutics annual EBITDA year-on-year change?
- What is Vera Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Vera Therapeutics?
- What is Vera Therapeutics quarterly EBITDA year-on-year change?
- What is Vera Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Vera Therapeutics?
- What is Vera Therapeutics TTM EBITDA year-on-year change?
What is Vera Therapeutics annual EBITDA?
The current annual EBITDA of VERA is -$92.20 M
What is the all time high annual EBITDA for Vera Therapeutics?
Vera Therapeutics all-time high annual EBITDA is -$11.29 M
What is Vera Therapeutics annual EBITDA year-on-year change?
Over the past year, VERA annual EBITDA has changed by -$4.14 M (-4.70%)
What is Vera Therapeutics quarterly EBITDA?
The current quarterly EBITDA of VERA is -$44.67 M
What is the all time high quarterly EBITDA for Vera Therapeutics?
Vera Therapeutics all-time high quarterly EBITDA is -$2.34 M
What is Vera Therapeutics quarterly EBITDA year-on-year change?
Over the past year, VERA quarterly EBITDA has changed by $0.00 (0.00%)
What is Vera Therapeutics TTM EBITDA?
The current TTM EBITDA of VERA is -$126.05 M
What is the all time high TTM EBITDA for Vera Therapeutics?
Vera Therapeutics all-time high TTM EBITDA is -$2.34 M
What is Vera Therapeutics TTM EBITDA year-on-year change?
Over the past year, VERA TTM EBITDA has changed by $0.00 (0.00%)